Interestingly, maternal obesity and excessive gestational weight gain had no significant effect on the concentrations of these organokines, with the exception of AFABP in the first and second trimesters, which presented higher levels in women with pregestational obesity. Here, FABP4 is linked to obesity due to melanocortin 4 receptor deficiency.